The Federal Trade Commission (FTC) successfully challenged the merger between Ottobock and Freedom Innovations, two leading prosthetic manufacturers, in an uncommon antitrust lawsuit. The FTC asserted that the merger would impede market competition and technological progress in the high-end prosthetic knee sector, despite the 2017 acquisition being small enough to evade initial regulatory examination. The primary legal contention revolved around whether the companies were direct competitors within a specific industry or part of a broader, more diverse market. Ultimately, the court mandated a complete divestiture of assets to a third party, rejecting attempts to invoke a “failing firm” rationale. This case serves as an important reminder that government oversight and potential enforced dissolution may arise years after private, undisclosed transactions finalize.
For a comprehensive article and graphic study of this case, click this link:
